In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.

Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a particular point in time or over a designated period. It reflects how widespread the disease is within the population and is typically expressed as a percentage or as the number of cases per a set number of individuals (e.g., per 1,000 or 100,000 people).

Prevalence also provides insight into the overall burden of disease in a population, making it essential for planning healthcare resources and services. However, it does not indicate the risk of developing the disease or the rate at which it is spreading.

Incidence, by contrast, measures the rate at which new cases of a disease occur in a population over a specified time period. This metric focuses on new cases, offering insight into the risk of contracting the disease and the dynamics of its spread.

Generally, incidence can be expressed in two ways:

  1. Incidence Rate (or Incidence Density): The number of new cases per person-time at risk (e.g., per 1,000 person-years).
  2. Cumulative Incidence (or Incidence Proportion): The proportion of an initially disease-free population that develops the disease over a specified period (e.g., the percentage of people who develop the disease within one year).

Incidence is crucial for understanding disease transmission dynamics and for assessing the effectiveness of preventive measures aimed at reducing new cases.

While prevalence and incidence are related, they capture different aspects of disease presence. Incidence focuses on the occurrence of new cases, while prevalence encompasses all existing cases. The prevalence of a disease in a population is influenced by both the incidence rate and the disease duration. For long-duration diseases, prevalence can remain high even if the incidence is low. Conversely, for diseases of short duration, prevalence may be low despite a high incidence rate.

Do Capítulo 14:

article

Now Playing

14.3 : Prevalence and Incidence

Biostatistics

151 Visualizações

article

14.1 : Visão geral da bioestatística em ciências da saúde

Biostatistics

165 Visualizações

article

14.2 : Introdução à Epidemiologia

Biostatistics

214 Visualizações

article

14.4 : Sensibilidade, especificidade e valor previsto

Biostatistics

59 Visualizações

article

14.5 : Gráfico de características operacionais do receptor

Biostatistics

35 Visualizações

article

14.6 : Desenhos de estudo em epidemiologia

Biostatistics

52 Visualizações

article

14.7 : Metodologia de superfície de resposta

Biostatistics

20 Visualizações

article

14.8 : Risco relativo

Biostatistics

30 Visualizações

article

14.9 : Razão de chances

Biostatistics

24 Visualizações

article

14.10 : Causalidade em Epidemiologia

Biostatistics

38 Visualizações

article

14.11 : Confusão em estudos epidemiológicos

Biostatistics

56 Visualizações

article

14.12 : Estratégias para avaliar e lidar com fatores de confusão

Biostatistics

48 Visualizações

article

14.13 : Critérios de Causalidade: Critérios de Bradford Hill - I

Biostatistics

31 Visualizações

article

14.14 : Critérios de Causalidade: Critérios de Bradford Hill - II

Biostatistics

23 Visualizações

article

14.15 : Viés em estudos epidemiológicos

Biostatistics

43 Visualizações

See More

JoVE Logo

Privacidade

Termos de uso

Políticas

Pesquisa

Educação

SOBRE A JoVE

Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados